gip glp-1 dual agonist Tirzepatide, a GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology The Sustained Effects of a

Based on my clinical experience, H1 receptor overactivation is one of the most underappreciated drivers of severe EMF sensitivity symptoms

NHS waiting times for bariatric surgery can be long - often over 12 months , depending on local availability and demand

At Mayfair Weight Loss Clinic, treatment recommendations are based on an individual clinical assessment to ensure the most appropriate licensed option is selected for each patient

Delivery 9am to 6pm Colombo 13 9am to 6pm Colombo 6 9am to 9pm Pelawatte 9am to 9pm Wattala 9am to 9pm

SUPPORTS METABOLISM L-Carnitine can help transport fat to be used for energy and to help improve body composition

For patients using GLP-1 therapy, the goal should not be scale weight alone